Cancer Immunology and Oncolytic Virology: Technologies and Global Markets

Mar 2014| PHM129A| BCC Publishing

Report Highlights

The global cancer immunotherapies market reached $30.8 billion in 2012. This market is expected to grow to nearly $34.3 billion in 2013 and $67.9 billion in 2018 with a compound annual growth rate (CAGR) of 14.7% over the five-year period, 2013 to 2018.

Report Includes

  • An overview of the global market for cancer immunotherapies
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of CAGRs through 2018.
  • Analyses of factors influencing market demand such as clinical guidelines, demographic changes, and market saturation
  • Technological discussion including the current state, newly issued patents, and pending applications
  • Profiles of leading companies in the industry.

SCOPE OF REPORT

The scope of this study entails the current immunology therapeutics markets for several of the most common cancers. The sectors covered are colony stimulating factors (CSFs), interferon alfa and gamma products, interleukin products and therapeutic monoclonal antibodies, including antibody conjugates, cancer vaccines and other cancer treatment immunology products. Vaccines against HPV and hepatitis B are included; while such vaccines act only indirectly against cancer, they do serve to protect against the disease. Also covered is oncolytic virology, so new that its market tables have been presented separately from the immunotherapy tables. The report also includes discussion of the regulatory environment, current and developing technologies, cancer incidence, market projections and market share, along with latest trends and clinical trials.

ANALYST CREDENTIALS

Valerie Kellogg is an experienced medical device and pharmaceutical professional with international market research experience. She has authored numerous reports on topics ranging from treatment of obesity to ablation devices, from wound care to treatment of chronic migraine. Her strong focus areas include treatment of chronic disease, the latest in surgical devices and analysis of potential acquisitions.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesPrice Member Price
Full Report: Cancer Immunology and Oncolytic Virology: Technologies and Global Markets106 $2,750 Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY 2$250Free
Chapter- 3: OVERVIEW 35$908Free
Chapter- 4: OVERVIEW OF CANCER IMMUNOTHERAPY28$726Free
Chapter- 5: ONCOLYTIC VIROTHERAPY10$259Free
Chapter- 6: MAJOR MARKETS 12$311Free
Chapter- 7: TECHNOLOGY4$104Free
Chapter- 8: COMPANY PROFILES12$311Free
Market Research Report

Single User License: $2750

Member Price: FREE

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
RELATED REPORTS
Share This Report